Letter

Few patients with prostate cancer are willing to be randomised to treatment

BMJ 1999; 318 doi: 10.1136/bmj.318.7197.1556a (Published 5 June 1999)
Cite this as: BMJ 1999;318:1556.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Paddy O'Reilly, Consultant urologist. (phoreilly@shurology.demon.co.uk),
  2. Linda Martin, Specialist urological nurse.,
  3. Gerald Collins, Consultant urological surgeon.
  1. on behalf of the CRASH Oncology Group, Stepping Hill Urology, Stepping Hill Hospital, Stockport SK2 7JE

    EDITOR—No one would deny the need for controlled prospective trials to determine best management in serious conditions such as prostate cancer. But to adopt a nihilistic approach towards available treatments because such data do not exist is to turn back the clock of progress. Proponents of evidence based medicine may claim that there is no evidence that radical …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular